Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved.

Pathology, research and practice - 1 Apr 2022

Mishra Sridhar, Kumari Swati, Srivastava Pallavi, Pandey Anshuman, Shukla Saumya, Husain Nuzhat

Abstract excerpt

Gallbladder cancer (GBC) carries a poor prognosis and frequently present in late stages of disease. Identification of targetable molecular changes for selecting appropriate treatment and identifying prognostic and therapeutic subsets is required. Next-generation sequencing (NGS) using a frequently mutated for GBC may provide a reference for clinical management. The primary aim of the current study was to analyze...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gallbladder Neoplasms
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Source

Identifiers

PMID: 35231860
DOI: 10.1016/j.prp.2022.153806

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved.PMID 35231860Read ↗

Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention.Semantic proximity Read ↗

Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patientsSemantic proximity Read ↗

Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practiceSemantic proximity Read ↗

Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patientsSemantic proximity Read ↗

Genomic landscape of gallbladder cancer: insights from whole exome sequencing.Semantic proximity Read ↗

Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational ApproachSemantic proximity Read ↗

Molecular characterization of gallbladder cancer using somatic mutation profiling.Semantic proximity Read ↗

Genomic and molecular landscape of gallbladder cancer elucidating pathogenic mechanisms novel therapeutic targets and clinical implications.Semantic proximity Read ↗

Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.Semantic proximity Read ↗

Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.Semantic proximity Read ↗

MAP Kinase and mammalian target of rapamycin are main pathways of gallbladder carcinogenesis: Results from bioinformatic analysis of Next Generation Sequencing data from a hospital-based cohortSemantic proximity Read ↗

Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.